Attached files
| file | filename |
|---|---|
| EX-31.2 - Apollo Medical Holdings, Inc. | v165362_ex31-2.htm |
| EX-32.2 - Apollo Medical Holdings, Inc. | v165362_ex32-2.htm |
| EX-31.1 - Apollo Medical Holdings, Inc. | v165362_ex31-1.htm |
| EX-32.1 - Apollo Medical Holdings, Inc. | v165362_ex32-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q/A
(MARK
ONE)
x AMENDMENT NO. 1 TO
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
AND
EXCHANGE ACT OF 1934
FOR THE
QUARTERLY PERIOD ENDED July 31, 2009
OR
¨ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES
AND EXCHANGE ACT OF 1934
COMMISSION
FILE NUMBER: 000-25809
APOLLO
MEDICAL HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
20-8046599
|
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
Identification
Number)
|
1010
N. Central Avenue
Glendale,
California 91202
(Address
of principal executive offices)
(818)
507-4617
Issuer’s
telephone number:
(Former Name or Former Address, if Changed Since Last Report)
Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days:
Yes x No
¨
Indicate
by check mark whether the registrant is a large accelerated filer, a
non-accelerated filer, or a smaller reporting company.
|
Large
accelerated filer ¨
|
Accelerated
filer ¨
|
|
Non-accelerated
filer ¨
|
Smaller
reporting company x
|
APOLLO
MEDICAL HOLDINGS, INC.
FORM
10-Q/A
For
the quarterly period ended July 31, 2009
TABLE
OF CONTENTS
|
PART
I
|
|
|
Explanatory
Note.
|
1
|
Explanatory
Note
This
Amendment No. 1 to the Quarterly Report on Form 10-Q/A (“Amendment
No. 1”), is being filed to amend the Company’s Quarterly Report on
Form 10-Q for the for the quarterly period ended July 31, 2009, previously
filed on September 4, 2009 (the “Original Filing”), in order to correct one of
the Company’s disclosures on the cover page of the Original Filing.
In
response to an inquiry on the cover page of the Original Filing (the “Cover Page
Inquiry”) on whether the Company has (i) filed all reports required to be filed
by Section 13 or 15(d) of the Exchange Act during the past 12 months, and (ii)
been subject to such filing requirements for the past 90 days, the Company
erroneously indicated “No.”
The
Company is filing this Amendment No. 1 to change its response to the Cover Page
Inquiry from “No” to “Yes,” and to correctly disclose that (i) it has filed all
reports required to be filed by Section 13 or 15(d) of the Exchange Act during
the past 12 months, and (ii) it has been subject to such filing requirements for
the past 90 days.
Except
for the foregoing correction, this Amendment No. 1 on Form 10-Q/A does
not amend or update any other information contained in the Original
Filing.
SIGNATURES
In
accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the
registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
APOLLO
MEDICAL HOLDINGS, INC.
|
||
|
Date: November
9, 2009
|
By:
|
/s/ A. NOEL DEWINTER
|
|
A.
Noel DeWinter
|
||
|
Chief
Financial Officer
|
||